Table 1: Drug-induced immune hemolytic anemia secondary to perioperative prophylactic use of cefotetan in obstetrics and gynecology.

Case

Publication

Procedure

Initial postoperative Hgb or HCT

Cefotetan-induced immune hemolytic anemia

Postoperative time to diagnosis (days)

Hgb or HCT

Reticulocyte count (%)

Bilirubin, Total (mg/dL)

Bilirubin, Indirect (mg/dL)

Lactate dihydrogen-ase (U/L)

Haptoglobin (mg/dL)

1

Shariatmadar [5]

Cesarean

---

2 weeks

14.80%

15

3.5

---

750

Normal

2

Naylor [6]

Cesarean

29%

13

11%

6.8

2.5

2.3

---

< 6

3

Cesarean

35%

9

23%

9.1

1.9

---

338

7

4

Cesarean

---

9

8%

11.1

5.4

4.8

448

---

5

Garratty [7]

Enterocele repair

11.6 g/dL

9

6.8 g/dL

---

---

6.1

---

< 5

6

Cesarean

7.5 g/dL

10

3.5 g/dL

30.6

---

5.4

607

< 50

7

Cesarean

9.9 g/dL

12

4.0 g/dL

---

---

2.2

1987

---

8

Cesarean

---

14

6.1 g/dL

---

---

---

---

---

9

Cesarean

9.6 g/dL

9

2.6 g/dL

---

5.3

---

1849

---

10

Cesarean

---

9

3.4 g/dL

---

27.6

---

2150

< 6

11

Cesarean

10.8 g/dL

9

3.7 g/dL

5.1

5

---

2967

---

12

Curettage

---

14

7.6 g/dL

2.5

---

3.1

233

< 6

13

Mohammed [8]

Colporrhaphy

11 g/dL, 32%

6

4.8 g/dL, 12.8%

3.2

5.2

---

1170

---

Hgb: Hemoglobin; HCT: Hematocrit